Stocks and Investing Stocks and Investing
Thu, March 16, 2023

Joseph Pantginis Reiterated (CAPR) at Strong Buy and Held Target at $18 on, Mar 16th, 2023


Published on 2024-10-28 02:17:40 - WOPRAI, Joseph Pantginis
  Print publication without navigation


Joseph Pantginis of HC Wainwright & Co., Reiterated "Capricor Therapeutics, Inc." (CAPR) at Strong Buy and Held Target at $18 on, Mar 16th, 2023.

Joseph, nor any peers, have made any analyst calls on CAPR in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources